Skip to content

Integra LifeSciences IART Finite-Lived Intangible Assets, Accumulated Amortization

Finite-Lived Intangible Assets, Accumulated Amortization at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
Axogen logo
AxogenAXGN
Globus Medical logo
Globus MedicalGMED
AbbVie logo
AbbVieABBV
Medtronic logo
MedtronicMDT
ITG
Integer HoldingsITGR

Other financials

Income statement

See full
Revenue$391.9M+2.4%
Gross profit$217.0M+11.6%
Operating income$11.5M+174%
Net income-$4.6M+81.7%
EPS (diluted)-$0.06+81.8%

Balance sheet

See full
Cash & equivalents$236.8M-1.0%
Total debt$2.0B+3.2%
Total equity$1.0B-31.6%
Total assets$3.6B-11.7%

Cash flow

See full
Operating cash flow$9.8M+187%
CapEx$14.8M-48.7%
Free cash flow-$5.0M+87.4%

Valuation

See full
Market cap$1.38B-56.8%
Enterprise value$3.12B-26.7%
P/S0.8×-1.1×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin-29.8%-30.3pp
Net margin-30.1%
FCF margin3.8%-6.3pp

Returns & leverage

See full
Return on equity-38.6%
Debt / equity1.9×+0.6×
Current ratio3.4×+2.2×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization.

The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's finite-lived intangible assets, accumulated amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Integra LifeSciences's finite-lived intangible assets, accumulated amortization?
Integra LifeSciences (IART) reported finite-lived intangible assets, accumulated amortization of $883.31M in Q1 2026.
How has Integra LifeSciences's finite-lived intangible assets, accumulated amortization changed year-over-year?
Integra LifeSciences's finite-lived intangible assets, accumulated amortization increased by 15.8% year-over-year, from $762.57M to $883.31M.
What is the long-term trend for Integra LifeSciences's finite-lived intangible assets, accumulated amortization?
Over 5 years (2020 to 2025), Integra LifeSciences's finite-lived intangible assets, accumulated amortization has grown at a 14.7% compound annual growth rate (CAGR), from $431.65M to $858.07M.